Increasing the efficiency of LNPs as therapeutic vehicles offers promise for better mRNA-based and gene editing treatment success.

Manifold Bio, a platform therapeutics company pioneering direct-to-vivo drug discovery, today announced a joint study with NVIDIA to validate Proteina-Complexa, NVIDIA's generative model for protein ...

Mayo Clinic researchers have developed a promising new way to deliver treatment directly to cholangiocarcinoma tumors, a rare and aggressive bile duct cancer with limited treatment options, using milk ...

For decades, lab-grown cells have been studied in materials that don't reflect the softness and flexibility of human tissue.

What if electronic circuits could be created simply by drawing lines with a pencil on paper or leaves—and then immediately ...

Encyclopedia Britannica – the world’s oldest continuously published English-language general encyclopedia – and its subsidiary Merriam-Webster have fi.

Coya Therapeutics, Inc. (NASDAQ: COYA) ("Coya" or the "Company"), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with ...

European companies have reportedly warned the European Union against rapidly reducing reliance on American technology ...

Financing demonstrates conviction in oligomer-selective approach and follows strong preclinical data, including in vitro, in vivo and non-human primate study results, that support development ...

Unable to absorb rising memory-chip prices, popular handset makers are passing on the costs to consumers Chinese smartphone maker Vivo on Monday said it will increase handset prices, citing surging ...